Table 4 The effects of Sumac supplementation on features of glycemic and lipid profile of adults with metabolic syndrome (with intention to treat method) (n = 47)a
| Â | Sumac groupb | Control groupc | Â | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Baseline | 6th week | Changed | Pe | Baseline | 6th week | Changed | Pe | Pf |
FBS (mg/dL) | 108.7 ± 30.9 | 108.0 ± 28.9 | -0.48 ± 13.4 | 0.80 | 108.2 ± 24.2 | 107.4 ± 25.4 | -0.74 ± 17.3 | 0.77 | 0.94 |
Serum triglyceride (mg/dL) | 177.0 ± 10.6 | 173.0 ± 10.36 | -4.00 ± 40.5 | 0.50 | 170.9 ± 11.5 | 185.9 ± 97.4 | 14.9 ± 56.7 | 0.07 | 0.10 |
Total cholesterol (mg/dL) | 165.9 ± 5.6 | 165.5 ± 5.5 | -0.44 ± 24.5 | 0.90 | 159.6 ± 34.7 | 168.5 ± 44.4 | 9.1 ± 23.7 | 0.01 | 0.12 |
HDL-c (mg/dL) | 44.5 ± 10.32 | 45.00 ± 11.4 | 0.51 ± 10.7 | 0.74 | 44.23 ± 10.5 | 44.80 ± 9.9 | 0.57 ± 10.3 | 0.70 | 0.98 |
LDL-c (mg/dL) | 86.0 ± 34.3 | 85.9 ± 32.0 | -0.16 ± 26.5 | 0.97 | 80.9 ± 30.3 | 86.6 ± 35.1 | 5.6 ± 20.4 | 0.07 | 0.34 |